Gordon Lithgow
Professor at The Buck Institute
Runs a research group studying the basic biology of aging and age-related disease. Team has made seminal discoveries including the identification of small molecules that slow aging.
Lithgow received his PhD in Genetics from the University of Glasgow, Scotland. He completed postdoctoral training at the Institute for Behavioral Genetics at the University of Colorado, Boulder. Lithgow was a Senior Lecturer in Molecular Gerontology at the School of Biological Sciences at the University of Manchester in England before coming to the Buck Institute in 2001. He is the Principal Investigator and Director of the Buck Institute’s Interdisciplinary Research Consortium on Geroscience. He is also the Principal Investigator of the Larry L. Hillblom Network on the Chemical Biology of Aging, and is the Coordinator of the Hillblom Center for the Biology of Aging Support Award.
Visit website: https://www.buckinstitute.org/lab/lithgow-lab/
See also: Buck Institute - Independent biomedical research institute focused on aging
Details last updated 03-Sep-2020
Gordon Lithgow News
Super summary of 3rd Annual Longevity Therapeutics Summit
Lifespan.io (LEAF) - 16-Feb-2021
More and more companies making greater and greater progress - 2021 could be an exciting year
Read more...Body builder supplement AKG extends lifespan and healthspan of mice
Buck Institute - 01-Sep-2020
Blood levels fall with age. NUS planning a clinical trial with middle-aged humans.
Read more...Metformin human trials planned
Diabetes.co.uk - 30-Nov-2015
Could significantly increase life expectancy and health span. 20 years ago aging was a biologica...
Read more...